30-day notice

1164

Federal Register / Vol. 87, No. 6 / Monday, January 10, 2022 / Notices

khammond on DSKJM1Z7X2PROD with NOTICES

20892, 301–480–7129, bryan.crenshaw@
nih.gov.
Name of Committee: Molecular, Cellular
and Developmental Neuroscience Integrated
Review Group; Cellular and Molecular
Biology of Glia Study Section.
Date: February 10–11, 2022.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sung-Wook Jang, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 812P,
Bethesda, MD 20892, (301) 435–1042,
[email protected].
Name of Committee: Interdisciplinary
Molecular Sciences and Training Integrated
Review Group; Enabling Bioanalytical and
Imaging Technologies Study Section.
Date: February 10–11, 2022.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kenneth Ryan, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3218,
MSC 7717, Bethesda, MD 20892, 301–435–
0229, [email protected].
Name of Committee: Biological Chemistry
and Macromolecular Biophysics Integrated
Review Group; Macromolecular Structure
and Function A Study Section.
Date: February 10–11, 2022.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: David R. Jollie, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4166,
MSC 7806, Bethesda, MD 20892, (301) 408–
9072, [email protected].
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: January 4, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

National Institutes of Health

National Institutes of Health

National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting

Submission for OMB Review; 30-Day
Comment Request Collection of
Customer Service, Demographic, and
Smoking/Tobacco Use Information
From the National Cancer Institute’s
(NCI) Cancer Information Service (CIS)

Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the contract
proposals, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Small Business Innovation
Research (SBIR) Phase II Program Contract
Solicitation (PHS 2020–1) Topic 084
Antiviral drugs to cure chronic hepatitis B
virus infection (N01).
Date: February 3, 2022.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3F26,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Noton K. Dutta, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3F26, Rockville, MD
20852, 240–669–2857, [email protected].
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: January 4, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–00137 Filed 1–7–22; 8:45 am]
BILLING CODE 4140–01–P

[FR Doc. 2022–00133 Filed 1–7–22; 8:45 am]
BILLING CODE 4140–01–P

VerDate Sep<11>2014

18:16 Jan 07, 2022

Jkt 256001

PO 00000

Frm 00059

Fmt 4703

Sfmt 4703

AGENCY:

National Institutes of Health,

HHS.
ACTION:

Notice.

In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30-days of the date of this
publication.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT: To
request more information on the
proposed project or to obtain a copy of
the data collection plans and
instruments, contact: Candace Maynard,
Branch Chief, Cancer Information
Service Branch, CISB/OCPL, 9609
Medical Center Drive, Rockville, MD
20850, or call non-toll-free number 240–
276–6657 or Email your request,
including your address to: deatonc@
mail.nih.gov. Formal requests for
additional plans and instruments must
be requested in writing.
SUPPLEMENTARY INFORMATION: This
proposed information collection was
previously published in the Federal
Register on October 20, 2021 (Vol. 86
FR 58082) and allowed 60 days for
public comment. No public comments
were received. The purpose of this
notice is to allow an additional 30 days
for public comment. The National
Cancer Institute (NCI), National
Institutes of Health, may not conduct or
sponsor, and the respondent is not
required to respond to, an information
collection that has been extended,
revised, or implemented on or after
October 1, 1995, unless it displays a
currently valid OMB control number.
SUMMARY:

E:\FR\FM\10JAN1.SGM

10JAN1

1165

Federal Register / Vol. 87, No. 6 / Monday, January 10, 2022 / Notices
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below.
Proposed Collection: Collection of
Customer Service, Demographic, and
Smoking/Tobacco use Information from
the National Cancer Institute’s (NCI)
Cancer Information Service (CIS), 0925–
0208, Expiration Date 2.28/2022,
REVISION, National Cancer Institute
(NCI), National Institutes of Health
(NIH).

Need and Use of Information
Collection: The National Cancer
Institute (NCI) currently collects: (1)
Customer service and demographic
information from clients of the Cancer
Information Service (CIS) in order to
properly plan, implement, and evaluate
cancer education efforts, including
assessing the extent by which the CIS
reaches and impacts underserved
populations; (2) smoking/tobacco use
behavior of individuals seeking NCI’s
smoking cessation assistance through
the CIS in order to provide smoking
cessation services tailored to the
individual client’s needs and track their
smoking behavior at follow up. This is

a request for OMB to approve a revised
submission for an additional three years
to provide ongoing customer service
collection of demographic information,
and collection of brief customer
satisfaction questions from NCI Cancer
Information Service Clients for the
purpose of program planning and
evaluation.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
5,818 hours.

ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent

Average time
per response
(in hours)

Total annual
burden hours

Category of respondent

Demographic & Customer Satisfaction
Questions (Appendix 1A or 1AB).
Demographic & Customer Satisfaction
Questions (Appendix 1B).
Smoking Cessation ‘‘Intake’’ Questions (Appendix 1C).
Smoking Call Backs (Appendix 1D) .............
VA Call Backs (Appendix 1E) .......................
Cancer Info Call Backs (Appendix 1F) .........
Email Intake Form (Appendix 2) ...................
Demographic & Customer Satisfaction
Questions (Appendix 9).

Individuals .............................

24,133

1

3/60

1,207

Individuals .............................

58,501

1

2/60

1,950

Individuals .............................

2,888

1

6/60

289

Individuals
Individuals
Individuals
Individuals
Individuals

.............................
.............................
.............................
.............................
.............................

2,904
8,166
2,242
8,796
578

1
1
1
1
1

4/60
4/60
4/60
10/60
2/60

194
544
149
1,466
19

Totals .....................................................

...............................................

........................

108,208

........................

5,818

Dated: January 5, 2022.
Diane Kreinbrink,
Project Clearance Liaison, National Cancer
Institute, National Institutes of Health.

applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.

[FR Doc. 2022–00230 Filed 1–7–22; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Complementary &
Integrative Health; Notice of Closed
Meeting

khammond on DSKJM1Z7X2PROD with NOTICES

Number of
respondents

Form name

Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant

VerDate Sep<11>2014

18:16 Jan 07, 2022

Jkt 256001

Name of Committee: National Center for
Complementary and Integrative Health
Special Emphasis Panel; Promoting Research
on Music and Health: Phased Innovation
Award for Music Interventions (R61/R33
Clinical Trial Optional) Video Assisted.
Date: February 11, 2022.
Time: 11:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Center for Complementary
and Integrative, Democracy II, 6707
Democracy Blvd., Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Shiyong Huang, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, Division of Extramural Activities,
NCCIH/NIH, 6707 Democracy Boulevard,
Suite 401, Bethesda, MD 20817,
[email protected].
(Catalogue of Federal Domestic Assistance
Program Nos. 93.213, Research and Training
in Complementary and Alternative Medicine,
National Institutes of Health, HHS)

PO 00000

Frm 00060

Fmt 4703

Sfmt 4703

Dated: January 4, 2022.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–00177 Filed 1–7–22; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HOMELAND
SECURITY
Federal Emergency Management
Agency
[Docket ID FEMA–2021–0002; Internal
Agency Docket No. FEMA–B–2191]

Proposed Flood Hazard
Determinations
Federal Emergency
Management Agency, Department of
Homeland Security.
ACTION: Notice.
AGENCY:

Comments are requested on
proposed flood hazard determinations,
which may include additions or
modifications of any Base Flood
Elevation (BFE), base flood depth,
Special Flood Hazard Area (SFHA)
boundary or zone designation, or

SUMMARY:

E:\FR\FM\10JAN1.SGM

10JAN1